Breaking News Instant updates and real-time market news.

GRFS

Grifols

$24.10

-0.605 (-2.45%)

, ARGX

Argenx

$98.39

-1.96 (-1.95%)

06:36
06/14/18
06/14
06:36
06/14/18
06:36

Grifols downgraded to Neutral ahead of competitor data at JPMorgan

JPMorgan analyst James Gordon last night downgraded Grifols to Neutral from Overweight and lowered his price target for the shares to $25.50 from $26.30. With 5% downside to consensus expectations in 2019 and 2020, the shares now look fully valued, Gordon tells investors in a research note. Further, the analyst sees competitor clinical data from Argenx (ARGX) and UCB in the second half of 2018 potentially raising questions as to the long-term sustainability of the auto-immune element of Grifols' immuno-globulin franchise.

GRFS

Grifols

$24.10

-0.605 (-2.45%)

ARGX

Argenx

$98.39

-1.96 (-1.95%)

  • 20

    Jun

GRFS Grifols
$24.10

-0.605 (-2.45%)

11/24/17
11/24/17
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. Deere (DE), upgraded to Buy from Hold at Deutsche Bank with analyst Nicole DeBlase saying positive earnings revisions should drive share outperformance from here. 2. Santander (SAN), upgraded to Buy from Neutral at Goldman Sachs. 3. Tim Participacoes (TSU), upgraded to Outperform from Market Perform at Itau BBA. 4. Grifols (GRFS), downgraded to Market Perform from Outperform at BBVA . 5. ZTO Express (ZTO), downgraded to Neutral from Buy at UBS with analyst Eric Lin citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/18
HSBC
03/14/18
UPGRADE
HSBC
Hold
Grifols upgraded to Hold from Reduce at HSBC
06/01/18
LEHM
06/01/18
INITIATION
LEHM
Overweight
Grifols initiated with an Overweight at Barclays
Barclays analyst Emily Field started Grifols with an Overweight rating and EUR 29 price target. The analyst views the company as the global leader in intravenous immunoglobulin therapy and thinks its investments "are about to pay off."
06/13/18
JPMS
06/13/18
DOWNGRADE
JPMS
Neutral
Grifols downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst James Gordon downgraded Grifols to Neutral with an unchanged price target of EUR 21.50. The analyst views the valuation as full at current share levels.
ARGX Argenx
$98.39

-1.96 (-1.95%)

11/16/17
WEDB
11/16/17
NO CHANGE
Target $41
WEDB
Outperform
Argenx price target raised to $41 from $26 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Argenx to $41 from $26 as he incorporates the pemphigus vulgaris market opportunity into his valuation. The analyst reiterates an Outperform rating on the shares.
12/19/17
PIPR
12/19/17
NO CHANGE
Target $100
PIPR
Overweight
Argenx price target raised to $100 from $32 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Argenx to $100 citing last week's positive Phase II efgartigimod data in myasthenia gravis. The analyst believes these data validate efgartigimod's mechanism of targeting FcRn to lower auto-antibodies to treat a broad range of autoimmune diseases. He reiterates an Overweight rating on Argenx shares.
04/09/18
RHCO
04/09/18
INITIATION
Target $125
RHCO
Buy
Argenx initiated with a Buy at SunTrust
SunTrust analyst Yatin Suneja initiated Argenx with a Buy rating and a price target of $125, saying the company is leveraging a proprietary antibody generation platform as its lead candidate ARGX-113 holds blockbuster potential in multiple autoimmune conditions. With the "solid proof-of-concept" already established in rare neuromuscular disease, the analyst contends that ARGX-113 could also have positive readouts in other indications. Suneja adds that Argenx's second asset - ARGX-110 - also has an "encouraging" potential in the early clinical data in leukemia.
06/07/18
PIPR
06/07/18
NO CHANGE
Target $130
PIPR
Overweight
Argenx price target raised to $130 from $100 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Argenx to $130 after the company reached an agreement with FDA to initiate a single Phase III trial of efgartigimod in generalized myasthenia gravis this year. Full Phase II data presented at the American Academy of Neurology conference showed "rapid and durable clinical benefit," Tenthoff tells investors in a research note. The analyst reiterates an Overweight rating on Argenx shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
06/19/18
06/19
12:17
06/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
06/19/18
06/19
12:16
06/19/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
06/19/18
06/19
12:15
06/19/18
12:15
Conference/Events
Stephens food/agribusiness analyst to hold an analyst/industry conference call »

Food & Agribusiness…

MUX

McEwen Mining

$2.18

0.035 (1.64%)

12:13
06/19/18
06/19
12:13
06/19/18
12:13
Hot Stocks
McEwen Mining COO Xavier Ochoa to resign effective July 13 »

On June 13, Xavier Ochoa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

GFN

General Finance Corp

$11.85

-0.05 (-0.42%)

12:10
06/19/18
06/19
12:10
06/19/18
12:10
Hot Stocks
Havner Family Trust buys 10K shares of General Finance »

The Havner Family Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$79.70

-0.83 (-1.03%)

12:10
06/19/18
06/19
12:10
06/19/18
12:10
Options
Put buyer opens downside hedge in Las Vegas Sands after record high »

Put buyer opens downside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

PTC

PTC

$97.72

-0.08 (-0.08%)

12:07
06/19/18
06/19
12:07
06/19/18
12:07
Hot Stocks
PTC, Elysium announce new design, validation app for ThingWorx Navigate »

PTC announced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$17.21

0.04 (0.23%)

12:05
06/19/18
06/19
12:05
06/19/18
12:05
Options
Kinder Morgan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$60.53

0.16 (0.27%)

, S

Sprint

$5.56

0.01 (0.18%)

12:03
06/19/18
06/19
12:03
06/19/18
12:03
Hot Stocks
T-Mobile, Sprint officially file merger plans with FCC »

T-Mobile US (TMUS) and…

TMUS

T-Mobile

$60.53

0.16 (0.27%)

S

Sprint

$5.56

0.01 (0.18%)

DTEGY

Deutsche Telekom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$195.71

-2.59 (-1.31%)

12:01
06/19/18
06/19
12:01
06/19/18
12:01
Periodicals
Facebook misses 'deadline' to answer Senator's questions, Bloomberg says »

Facebook has missed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TCI

Transcontinental Realty Inc

$36.00

2.54 (7.59%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Transcontinental Realty, Adobe Properties say advisor may make stock purchases »

Transcontinental Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$29.00

-3.07 (-9.57%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Smartsheet falls -9.9% »

Smartsheet is down -9.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYX

Systemax

$35.40

-4 (-10.15%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Systemax falls -10.5% »

Systemax is down -10.5%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$125.30

-2.2 (-1.73%)

, EADSY

Airbus

$0.00

(0.00%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Periodicals
Pratt & Whitney close to fix for part that delayed Airbus jets, Bloomberg says »

Pratt & Whitney,…

UTX

United Technologies

$125.30

-2.2 (-1.73%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$27.24

-4.92 (-15.30%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
PagSeguro Digital falls -15.1% »

PagSeguro Digital is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

EBR

Centrais Electricas

$3.71

0.21 (6.00%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Centrais Electricas rises 6.3% »

Centrais Electricas is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$10.44

0.795 (8.24%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 8.0% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COTV

Cotiviti Holdings

$44.02

4.13 (10.35%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Cotiviti Holdings rises 10.4% »

Cotiviti Holdings is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$17.90

0.4 (2.29%)

11:57
06/19/18
06/19
11:57
06/19/18
11:57
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 30

    Jun

  • 30

    Jun

VZ

Verizon

$48.69

1.23 (2.59%)

11:57
06/19/18
06/19
11:57
06/19/18
11:57
Periodicals
Verizon to cease sharing phone-location data of customers, Reuters reports »

Verizon will stop sharing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

USCR

U.S. Concrete

$63.30

-1.1 (-1.71%)

11:53
06/19/18
06/19
11:53
06/19/18
11:53
Hot Stocks
U.S. Concrete rating downgraded to B2 from B1 by Moody's »

Moody's Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

JD

JD.com

$41.57

-2.18 (-4.98%)

11:50
06/19/18
06/19
11:50
06/19/18
11:50
Options
Continued interest in JD Jun 22nd 45 calls even as shares slide »

Continued interest in JD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
06/19/18
06/19
11:50
06/19/18
11:50
General news
Treasury's bill auctions were about average »

Treasury's bill…

KO

Coca-Cola

$43.57

0.01 (0.02%)

11:47
06/19/18
06/19
11:47
06/19/18
11:47
Hot Stocks
Arby's announces conversion to Coca-Cola beverages »

Arby's announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$44.44

0.09 (0.20%)

, FOXA

21st Century Fox

$44.70

0.145 (0.33%)

11:43
06/19/18
06/19
11:43
06/19/18
11:43
Hot Stocks
21st Century Fox says 'looks forward' to final decision clearing transaction »

21st Century Fox (FOXA)…

FOX

21st Century Fox

$44.44

0.09 (0.20%)

FOXA

21st Century Fox

$44.70

0.145 (0.33%)

SKYAY

Sky

$0.00

(0.00%)

DIS

Disney

$106.00

-1.05 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.